SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
10534246
Source:
http://linkedlifedata.com/resource/pubmed/id/10534246
Search
Subject
(
62
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0035647
,
umls-concept:C0058698
,
umls-concept:C0678951
,
umls-concept:C1335671
,
umls-concept:C1970038
pubmed:issue
7
pubmed:dateCreated
1999-11-3
pubmed:abstractText
To investigate whether polymorphisms in the genes for dopamine receptors D1 and D2 are associated with the risk of developing peak-dose dyskinesias in PD.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/10534246-11889264
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0401060
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antiparkinson Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Levodopa
,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Dopamine D2
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0028-3878
pubmed:author
pubmed-author:AgugliaUU
,
pubmed-author:AndreoliVV
,
pubmed-author:AnnesiGG
,
pubmed-author:BrancaDD
,
pubmed-author:CittadellaRR
,
pubmed-author:CivitelliDD
,
pubmed-author:GambardellaAA
,
pubmed-author:MontesantiRR
,
pubmed-author:NicolettiGG
,
pubmed-author:OliveriR LRL
,
pubmed-author:PasquaA AAA
,
pubmed-author:QuattroneAA
,
pubmed-author:SpadaforaPP
,
pubmed-author:ZappiaMM
pubmed:issnType
Print
pubmed:day
22
pubmed:volume
53
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1425-30
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:10534246-Adult
,
pubmed-meshheading:10534246-Aged
,
pubmed-meshheading:10534246-Alleles
,
pubmed-meshheading:10534246-Antiparkinson Agents
,
pubmed-meshheading:10534246-Case-Control Studies
,
pubmed-meshheading:10534246-Dyskinesia, Drug-Induced
,
pubmed-meshheading:10534246-Dyskinesias
,
pubmed-meshheading:10534246-Female
,
pubmed-meshheading:10534246-Gene Frequency
,
pubmed-meshheading:10534246-Genetic Predisposition to Disease
,
pubmed-meshheading:10534246-Humans
,
pubmed-meshheading:10534246-Levodopa
,
pubmed-meshheading:10534246-Male
,
pubmed-meshheading:10534246-Middle Aged
,
pubmed-meshheading:10534246-Parkinson Disease
,
pubmed-meshheading:10534246-Polymorphism, Genetic
,
pubmed-meshheading:10534246-Receptors, Dopamine D2
,
pubmed-meshheading:10534246-Tandem Repeat Sequences
pubmed:year
1999
pubmed:articleTitle
Dopamine D2 receptor gene polymorphism and the risk of levodopa-induced dyskinesias in PD.
pubmed:affiliation
Institute of Neurology, Department of Medical Sciences, University of Catanzaro, Italy.
pubmed:publicationType
Journal Article